Endometrial Cell Collection With the PadKit

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

May 30, 2026

Study Completion Date

May 30, 2026

Conditions
Neoplasms
Interventions
DEVICE

PadKit™ from Preprogen

"The interlabial pad is classified as a Class 1 device by the FDA and the device is exempt from requiring a 510(k) approval.~The interlabial pad is worn for 4-6 consecutive hours and collects cells shed from the cervix and uterine cavity. The pad is then removed and placed in the smaller, inner tube that contains the transport solution. After replacing the lid securely, it is then carefully placed back inside the larger outer tube with the outer lid secured and returned to the original box. The entire box is placed in the polybag and mailed back to the lab for analysis."

Trial Locations (2)

07753

RECRUITING

Jersey Shore University Medical Center, Neptune City

07701

RECRUITING

Riverview Medical Center, Red Bank

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Preprogen

UNKNOWN

lead

Hackensack Meridian Health

OTHER